PAUL J. DIAZ - 30 Apr 2025 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: President and CEO, Director
Signature: By: Justin Hunter For: Paul J. Diaz
Issuer symbol: MYGN
Transactions as of: 30 Apr 2025
Transactions value $: $0
Form type: 4
Filing time: 30 Apr 2025, 17:32:00 UTC
Previous filing: 25 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MYGN	Common Stock						891,844	30 Apr 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MYGN	Time-Based Stock Option						342,040	30 Apr 2025	Common Stock	342,040	$13.38	Direct
holding	MYGN	Performance-Based Stock Option						339,088	30 Apr 2025	Common Stock	339,088	$13.38	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

PAUL J. DIAZ is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the roles of Director and President and Chief Executive Officer of the Company, effective April 30, 2025, and therefore is no longer subject to Section 16 reporting.